Andere Sprachen Surgery Partners, Inc.

Aktien

A14YWP

US86881A1007

SGRY

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
25,5 ^USD	+0,47 %		+4,21 %	-20,29 %

26.03.	Surgery Partners Einheit bietet vorrangige Anleihen im Wert von $600 Millionen an	MT
06.03.	Insider von Surgery Partners verkaufte Aktien im Wert von $277.633, laut einer aktuellen SEC Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Surgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Details	18.04.
Surgery Partners Unit to Offer $600 Million of Senior Notes	26.03.
Surgery Partners, Inc. Announces New Senior Notes Offering	26.03.
Surgery Partners Insider Sold Shares Worth $277,633, According to a Recent SEC Filing	06.03.
Surgery Partners Q4 Adjusted Earnings, Revenue Climb	26.02.
Earnings Flash (SGRY) SURGERY PARTNERS Posts Q4 EPS $0.44, vs. Street Est of $0.38	26.02.
Surgery Partners: Q4 Earnings Snapshot	26.02.
Surgery Partners, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26.02.
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2023 Results; Sets 2024 Guidance	26.02.
Surgery Partners, Inc. Provides Earnings Guidance for the Year 2024	26.02.
Surgery Partners, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26.02.
North American Morning Briefing : Traders Await -2-	26.02.
Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details	08.02.
Certain Stock Options of Surgery Partners, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2024.	29.01.
Certain Common Stock of Surgery Partners, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2024.	29.01.
Sheridan Capital Partners-Backed Oral Surgery Partners Announces $400M Credit Expansion, Multiple Acquisitions, and C-Suite Hires	23.01.
Surgery Partners Seeks M&A	08.01.
Surgery Partners Reiterates 2023 Revenue Outlook of $2.75 Billion	08.01.
Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook	08.01.
Surgery Partners, Inc. Reaffirms Earnings Guidance for the Year 2023	08.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Surgery Partners, Inc.

Aktien

A14YWP

US86881A1007

SGRY

Andere Sprachen

Filter